Common Stock, Shares, Issued of NeuroSense Therapeutics Ltd. from 31 Dec 2022 to 30 Jun 2025

Taxonomy & unit: us-gaap: shares
Description: Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary: NeuroSense Therapeutics Ltd. quarterly Common Stock, Shares, Issued in shares history and change rate from 31 Dec 2022 to 30 Jun 2025.
NeuroSense Therapeutics Ltd. Common Stock, Shares, Issued for the quarter ending 30 Jun 2025 was 24,602,405, a 36% increase year-over-year.
Source SEC data: View on sec.gov

Common Stock, Shares, Issued, Quarterly (shares)

Common Stock, Shares, Issued, YoY Quarterly Change (%)

NeuroSense Therapeutics Ltd. Quarterly Common Stock, Shares, Issued (shares)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2025	24,602,405	+6,547,399	+36%	30 Jun 2025	6-K	01 Aug 2025	2025	Q2
Q4 2024	23,228,941	+7,849,899	+51%	31 Dec 2024	6-K	01 Aug 2025	2025	Q2
Q2 2024	18,055,006			30 Jun 2024	6-K	30 Sep 2024	2024	Q2
Q4 2023	15,379,042	+3,597,079	+31%	31 Dec 2023	20-F	07 Apr 2025	2024	FY
Q4 2022	11,781,963			31 Dec 2022	6-K	17 Jun 2024	2023	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.